← back to search

Bernhard Gentner

University of Lausanne · CH
Area of research
Genetics · Oncology
Research interest
Research interests include Haematopoiesis, Cancer research, Immunology, Stem cell, Biology, and Myeloid leukemia.
h-index
citations
1,399
works
12
NIH funding
primary concept
email

Recent publications

Circulating hematopoietic stem/progenitor cell subsets contribute to human hematopoietic homeostasis
Blood 2024cited by 22position: middledoi
Phase II trial of hypomethylating agent combined with nivolumab for acute myeloid leukaemia relapse after allogeneic haematopoietic cell transplantation—Immune signature correlates with response
British Journal of Haematology 2023cited by 18position: middledoi
Myeloid cell‐based delivery of IFN‐γ reprograms the leukemia microenvironment and induces anti‐tumoral immune responses
EMBO Molecular Medicine 2021cited by 29position: lastdoi
Pro‐inflammatory cytokines favor the emergence of ETV6‐RUNX1‐positive pre‐leukemic cells in a model of mesenchymal niche
British Journal of Haematology 2020cited by 34position: middledoi
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation
Nature Medicine 2019cited by 398position: middledoi
Impaired X-CGD T cell compartment is gp91phox-NADPH oxidase independent
Clinical Immunology 2018cited by 7position: middledoi
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease
Blood 2017cited by 83position: middledoi
Hematopoietic stem cell gene therapy for IFNγR1 deficiency protects mice from mycobacterial infections
Blood 2017cited by 24position: middledoi
miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells
Cancer Cell 2016cited by 265position: middledoi
MicroRNA-223 dose levels fine tune proliferation and differentiation in human cord blood progenitors and acute myeloid leukemia
Experimental Hematology 2015cited by 34position: firstdoi
CD44v6-targeted T cells mediate potent antitumor effects against acute myeloid leukemia and multiple myeloma
Blood 2013cited by 350position: middledoi
miR-142-3p Prevents Macrophage Differentiation during Cancer-Induced Myelopoiesis
Immunity 2013cited by 135position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Luigi Naldini · Vita-Salute San Raffaele University5 papers (2013–2021)Monica Casucci · Vita-Salute San Raffaele University3 papers (2013–2021)Maurilio Ponzoni · Vita-Salute San Raffaele University2 papers (2013–2017)Fabio Ciceri · Vita-Salute San Raffaele University2 papers (2013–2017)Adele Mucci · Medizinische Hochschule Hannover2 papers (2017–2021)Nico Lachmann · Medizinische Hochschule Hannover2 papers (2017–2021)Pietro Genovese · Harvard Stem Cell Institute2 papers (2013–2017)Attilio Bondanza · Novartis (Switzerland)2 papers (2013–2017)Chiara Bonini · University of Rome Tor Vergata2 papers (2013–2017)Giulia Escobar · Harvard University2 papers (2017–2021)Barbara Camisa · Vita-Salute San Raffaele University2 papers (2013–2017) · 1 papers (2013–2013) · 1 papers (2020–2020)Mark Kühnel · Medizinische Hochschule Hannover1 papers (2017–2017)Tobias Berg · Hamilton Health Sciences1 papers (2015–2015) · 1 papers (2017–2017)Pablo Menéndez · Universitat de Barcelona1 papers (2020–2020)Christian Trautwein · FH Aachen1 papers (2013–2013)Giacomo Oliveira · Harvard University1 papers (2017–2017) · 1 papers (2015–2015)